Vice President of Experimental Medicine Early Development, Oncology Therapeutic Area
San Francisco, California
Janssen Pharmaceuticals â
Vice President of Experimental Medicine Early Development, Oncology Therapeutic Area
Forty Seven
Chief Medical Officer
START- South Texas Accelerated Research Therapeutics
Director of Pharmacology
Gilead Sciences
Senior Vice President
Institute for Drug Development/Cancer Therapy and Research Center
Director of Pharmacology and Zachry Chair for Translational Research
IGM Biosciences Inc
Chief Medical Officer
Ortho Biotech Oncology R&D/Johnson & Johnson
Senior Director, Translational Medicine
SWOG - Leading cancer research. Together.
Chair, Early Therapeutics Committee
Tizona Therapeutics, Inc.
Member Board Of Directors
Forty Seven, Inc.
Chief Medical Officer
Janssen, Pharmaceutical Companies of Johnson and Johnson
Vice President, Experimental Medicine Early Development, Oncology Therapeutic Area
UTHSCSA
Professor of Pharmacology (Adjunct)
Yale University
Yale University School of Medicine
Uniformed Services University
National Cancer Institute
University of California, San Francisco